+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

United States Diabetes Care Devices Market Outlook to 2025 - Glucose Monitoring and Insulin Delivery

  • ID: 5026869
  • Report
  • April 2020
  • Region: United States
  • 167 Pages
  • GlobalData
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • DexCom Inc
  • Medtronic Plc
  • Novo Nordisk AS
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Summary

“United States Diabetes Care Devices Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States Diabetes Care Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Glucose Monitoring and Insulin Delivery.

The United States Diabetes Care Devices Market report provides key information and data on -
  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
  • 2019 company share and distribution share data for Diabetes Care Devices Market.
  • Global corporate-level profiles of key companies operating within the United States Diabetes Care Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United States Diabetes Care Devices is segmented as follows -
  • Glucose Monitoring and Insulin Delivery

Reasons to Buy

The United States Diabetes Care Devices Market report helps you to develop -
  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Understand the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • DexCom Inc
  • Medtronic Plc
  • Novo Nordisk AS

Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Diabetes Care Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Diabetes Care Devices Market, United States
3.1 Diabetes Care Devices Market, United States, Revenue ($m), 2015-2025
3.2 Diabetes Care Devices Market, United States, Revenue Mix ($m), 2019
3.3 Diabetes Care Devices Market, United States, Category Contribution by Revenue ($m), 2019
3.4 Diabetes Care Devices Market, United States, Revenue ($m), 2015-2025
3.5 Diabetes Care Devices Market, United States, Volume (Units), 2015-2025
3.6 Diabetes Care Devices Market, United States, Volume (Units), 2015-2025
3.7 Diabetes Care Devices Market, United States, Company Share by Revenue ($m), 2019
4 Glucose Monitoring Market, United States
4.1 Glucose Monitoring Market, United States, Revenue ($m), 2015-2025
4.1.1 Blood Glucose Meters Market, United States, Revenue ($m), by Segment, 2015-2025
4.2 Glucose Monitoring Market, United States, Volume (Units), 2015-2025
4.2.1 Blood Glucose Meters Market, United States, Volume (Units), by Segment, 2015-2025
4.3 Glucose Monitoring Market, United States, Average Price ($) , 2015-2025
4.4 Glucose Monitoring Market, United States, Distribution Share by Revenue ($m), 2019
4.5 Glucose Monitoring Market, United States, Company Share by Revenue ($m), 2019
5 Insulin Delivery Market, United States
5.1 Insulin Delivery Market, United States, Revenue Mix ($m), 2019
5.2 Insulin Delivery Market, United States, Segment Contribution (%), 2019
5.3 Insulin Delivery Market, United States, Revenue ($m), 2015-2025
5.3.1 Insulin Pens Market, United States, Revenue ($m), by Segment, 2015-2025
5.3.2 Insulin Pumps Market, United States, Revenue ($m), by Segment, 2015-2025
5.4 Insulin Delivery Market, United States, Volume (Units), 2015-2025
5.4.1 Insulin Pens Market, United States, Volume (Units), by Segment, 2015-2025
5.4.2 Insulin Pumps Market, United States, Volume (Units), by Segment, 2015-2025
5.5 Insulin Delivery Market, United States, Average Price ($), 2015-2025
5.6 Insulin Delivery Market, United States, Distribution Share by Revenue ($m), 2019
5.7 Insulin Delivery Market, United States, Company Share by Revenue ($m), 2019
6 Overview of Key Companies in United States, Diabetes Care Devices Market
6.1 DexCom Inc
6.1.1 Company Overview
6.2 Medtronic Plc
6.2.1 Company Overview
6.3 Novo Nordisk AS
6.3.1 Company Overview
6.4 Eli Lilly and Co
6.4.1 Company Overview
6.5 Abbott Laboratories
6.5.1 Company Overview
6.6 Sanofi
6.6.1 Company Overview
6.7 Insulet Corp
6.7.1 Company Overview
7 Diabetes Care Devices Market Pipeline Products
8 Financial Deals Landscape
8.1 Acquisition
8.1.1 CCS Medical Holdings May Sell Itself
8.1.2 KNOW Bio Acquires Clinical Sensors
8.1.3 Medtronic Acquires Klue
8.1.4 Cerecor Acquires Aevi Genomic Medicine
8.1.5 Dare Bioscience Acquires Microchips Biotech
8.1.6 Best Buy Acquires Critical Signal Technologies
8.2 Debt Offerings
8.2.1 Thermo Fisher Scientific Prices Public Offering of 2.375% Notes Due 2032 for USD668 Million
8.2.2 Thermo Fisher Scientific Prices Public Offering of 1.750% Notes Due 2027 for USD668 Million
8.2.3 Pfizer Raises USD1.25 Billion in Public Offering of 2.625% Notes Due 2030
8.2.4 Thermo Fisher Scientific Prices Public Offering of 4.133% Notes Due 2025 for USD1.1 Billion
8.2.5 Thermo Fisher Scientific Prices Public Offering of 4.497% Notes Due 2030 for USD1.1 Billion
8.2.6 Guided Therapeutics Raises USD0.7 Million in Public Offering of Convertible Note
8.2.7 Eli Lilly Prices Public Offering of 0.625% Notes Due 2031 for USD665.5 Million
8.2.8 Eli Lilly Prices Public Offering of 1.7% Notes Due 2049 for USD1.1 Billion
8.2.9 Thermo Fisher Scientific Raises USD990 Million in Public Offering of 1.500% Notes Due 2039
8.2.10 Thermo Fisher Scientific Raises USD900 Million in Public Offering of 2.600% Notes Due 2029
8.2.11 Thermo Fisher Scientific Raises USD1.1 Billion in Public Offering of 1.875% Notes Due 2049
8.2.12 Thermo Fisher Scientific Raises USD880 Million in Public Offering of 0.500% Notes Due 2028
8.2.13 Thermo Fisher Scientific Raises USD990 Million in Public Offering of 0.875% Notes Due 2031
8.2.14 Thermo Fisher Scientific Raises USD880 Million in Public Offering of 0.125% Notes Due 2025
8.2.15 Insulet Raises USD800 Million in 0.375% Convertible Senior Notes Due 2026
8.2.16 Senseonics Holdings Raises USD82 Million in Private Placement of 5.25% Notes Due 2025
8.2.17 Becton Dickinson Raises USD669.7 Million in Public Offering of 0.174% Notes Due 2021
8.2.18 Becton Dickinson Raises USD669.7 Million in Public Offering of 1.208% Notes Due 2026
8.2.19 Becton Dickinson Raises USD893 Million in Public Offering of 0.632% Notes due 2023
8.3 Equity Offerings
8.3.1 Tenax Therapeutics Prices Private Placement of Shares and Warrants for USD2.8 Million
8.3.2 Xeris Pharma Raises USD42.7 Million in Public Offering of Shares
8.3.3 Albireo Pharma Raises USD46 Million in Public Offering of Shares
8.3.4 Guided Therapeutics Raises USD0.7 Million in Private Placement of Units
8.3.5 PhysioLogic Devices Raises Funds through Financing
8.3.6 Senseonics Plans to Raise up to USD50 Million in Public Offering of Shares
8.3.7 Organogenesis Prices USD45 Million Public Offering of Shares
8.3.8 Organogenesis Plans to Raise up to USD100 Million in Public Offering of Securities
8.3.9 Xeris Pharma Plans to Raise up to USD50 Million in Public Offering of Shares
8.3.10 Valeritas Holdings Plans to Raise up to USD10.7 Million in Public Offering of Shares
8.3.11 Senseonics Holdings Raises USD25 Million in Public Offering of Shares
8.3.12 Glucose Biosensor Systems Files Registration Statement for IPO of Shares
8.3.13 MannKind to Raise up to USD50 Million in Public Offering of Shares
8.3.14 Dance Biopharm Raises USD20.5 Million in Private Placement
8.4 Partnerships
8.4.1 Abbott Labs and Insulet Enter into Partnership
8.4.2 Biocorp Production Enters into Agreement with Amalgam Rx (iSage Rx)
8.4.3 Senseonics Enters into Partnership with Companion Medical
8.4.4 Abbott Labs Enters into Agreement with Bigfoot Biomedical
8.4.5 Trividia Health and Mellitus Health Form Partnership
8.4.6 Solys Diagnostics Enters into Licensing Agreement with Liquid Sensing
8.4.7 Sanofi and Abbott Enter into Partnership
8.4.8 Medtronic and Tidepool to Enter into Partnership
8.4.9 LifeScan Enters into Distribution Agreement with Sanvita Medical
8.5 Private Equity
8.5.1 Becton Dickinson Shareholders Reject Mini Tender Offer from TRC Capital
8.5.2 Blackstone Group and Cinven May Bid for Smiths Medical
8.5.3 AgaMatrix and WaveForm Technologies Raises USD56 Million in Financing
8.6 Venture Financing
8.6.1 Modular Medical to Raise Funds through Venture Financing
8.6.2 Fractyl Labs Raises USD44.8 Million in Venture Financing
8.6.3 Bigfoot Biomedical Raises USD45 Million in Initial Tranche of Series C Financing
8.6.4 VivaChek Labs Raises USD14.2 Million in Series C Financing
8.6.5 Hygieia Raises USD1.3 Million in Venture Financing
8.6.6 Eccrine Systems Raises USD1.9 Million in Venture Financing
8.6.7 Accessible Diagnostics Raises USD0.2 Million in Venture Financing
8.6.8 Amalgam Rx (iSage Rx) Secures USD0.65 Million in Venture Financing
8.6.9 MuscleSound Raises USD0.8 Million in Venture Financing
8.6.10 Informed Data Systems (One Drop) Raises USD40 Million in Series B Financing
8.6.11 TecMed Raises Funds through Venture Financing
8.6.12 Thermalin Raises Additional USD12.2 Million in Venture Financing
8.6.13 VivaChek Laboratories Raises Funds through Venture Financing
8.6.14 POPS! Diabetes Care Secures USD6 Million in Series A Funding
8.6.15 Beta Bionics Raises USD63 Million in Series B2 Financing
8.6.16 Encellin Raises USD1.6 Million in Venture Financing
8.6.17 Eccrine Systems Raises USD0.6 Million in Venture Financing
8.6.18 PhysioLogic Devices to Raise USD3 Million in Venture Financing
8.6.19 Intuity Medical (Rosedale Medical) Raises USD26.27 Million in Venture Financing
8.6.20 Mighty Well Raises Funds through Venture Financing
9 Appendix
9.1 Research Methodology
9.1.1 Coverage
9.1.2 Secondary Research
9.1.3 Primary Research
9.1.4 Market Modeling and Forecasting
9.1.5 Company Share Analysis
9.1.6 Distribution Share Analysis
9.1.7 Benchmarking
9.2 Consulting
9.3 Contact
9.4 Disclaimer
List of Tables
Table 1: Diabetes Care Devices Market, United States, Revenue ($m), USD Constant, 2015-2025
Table 2: Diabetes Care Devices Market, United States, Category Contribution by Revenue ($m), 2019
Table 3: Diabetes Care Devices Market, United States, Revenue ($m), USD Constant, Historic, 2015-2020
Table 4: Diabetes Care Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2021-2025
Table 5: Diabetes Care Devices Market, United States, Volume (Units), 2015-2025
Table 6: Diabetes Care Devices Market, United States, Volume (Units), Historic, 2015-2020
Table 7: Diabetes Care Devices Market, United States, Volume (Units), Forecast, 2021-2025
Table 8: Diabetes Care Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2019
Table 9: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 10: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 11: Blood Glucose Meters Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 12: Blood Glucose Meters Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 13: Glucose Monitoring Market, United States, Volume (Units), 2015-2020
Table 14: Glucose Monitoring Market, United States, Volume (Units), 2021-2025
Table 15: Blood Glucose Meters Market, United States, Volume (Units), 2015-2020
Table 16: Blood Glucose Meters Market, United States, Volume (Units), 2021-2025
Table 17: Glucose Monitoring Market, United States, Average Price ($), 2015-2020
Table 18: Glucose Monitoring Market, United States, Average Price ($), 2021-2025
Table 19: Glucose Monitoring Market, United States, Distribution Share by Revenue ($m), USD Constant, 2019
Table 20: Glucose Monitoring Market, United States, Company Share by Revenue ($m), USD Constant, 2019
Table 21: Insulin Delivery Market, United States, Segment Contribution (%), 2019
Table 22: Insulin Delivery Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 23: Insulin Delivery Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 24: Insulin Pens Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 25: Insulin Pens Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 26: Insulin Pumps Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 27: Insulin Pumps Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 28: Insulin Delivery Market, United States, Volume (Units), 2015-2020
Table 29: Insulin Delivery Market, United States, Volume (Units), 2021-2025
Table 30: Insulin Pens Market, United States, Volume (Units), 2015-2020
Table 31: Insulin Pens Market, United States, Volume (Units), 2021-2025
Table 32: Insulin Pumps Market, United States, Volume (Units), 2015-2020
Table 33: Insulin Pumps Market, United States, Volume (Units), 2021-2025
Table 34: Insulin Delivery Market, United States, Average Price ($), 2015-2020
Table 35: Insulin Delivery Market, United States, Average Price ($), 2021-2025
Table 36: Insulin Delivery Market, United States, Distribution Share by Revenue ($m), USD Constant, 2019
Table 37: Insulin Delivery Market, United States, Company Share by Revenue ($m), USD Constant, 2019
Table 38: Diabetes Care Devices Market Pipeline Products
Table 39: CCS Medical Holdings May Sell Itself
Table 40: KNOW Bio Acquires Clinical Sensors
Table 41: Medtronic Acquires Klue
Table 42: Cerecor Acquires Aevi Genomic Medicine
Table 43: Dare Bioscience Acquires Microchips Biotech
Table 44: Best Buy Acquires Critical Signal Technologies
Table 45: Thermo Fisher Scientific Prices Public Offering of 2.375% Notes Due 2032 for USD668 Million
Table 46: Thermo Fisher Scientific Prices Public Offering of 1.750% Notes Due 2027 for USD668 Million
Table 47: Pfizer Raises USD1.25 Billion in Public Offering of 2.625% Notes Due 2030
Table 48: Thermo Fisher Scientific Prices Public Offering of 4.133% Notes Due 2025 for USD1.1 Billion
Table 49: Thermo Fisher Scientific Prices Public Offering of 4.497% Notes Due 2030 for USD1.1 Billion
Table 50: Guided Therapeutics Raises USD0.7 Million in Public Offering of Convertible Note
Table 51: Eli Lilly Prices Public Offering of 0.625% Notes Due 2031 for USD665.5 Million
Table 52: Eli Lilly Prices Public Offering of 1.7% Notes Due 2049 for USD1.1 Billion
Table 53: Thermo Fisher Scientific Raises USD990 Million in Public Offering of 1.500% Notes Due 2039
Table 54: Thermo Fisher Scientific Raises USD900 Million in Public Offering of 2.600% Notes Due 2029
Table 55: Thermo Fisher Scientific Raises USD1.1 Billion in Public Offering of 1.875% Notes Due 2049
Table 56: Thermo Fisher Scientific Raises USD880 Million in Public Offering of 0.500% Notes Due 2028
Table 57: Thermo Fisher Scientific Raises USD990 Million in Public Offering of 0.875% Notes Due 2031
Table 58: Thermo Fisher Scientific Raises USD880 Million in Public Offering of 0.125% Notes Due 2025
Table 59: Insulet Raises USD800 Million in 0.375% Convertible Senior Notes Due 2026
Table 60: Senseonics Holdings Raises USD82 Million in Private Placement of 5.25% Notes Due 2025
Table 61: Becton Dickinson Raises USD669.7 Million in Public Offering of 0.174% Notes Due 2021
Table 62: Becton Dickinson Raises USD669.7 Million in Public Offering of 1.208% Notes Due 2026
Table 63: Becton Dickinson Raises USD893 Million in Public Offering of 0.632% Notes due 2023
Table 64: Tenax Therapeutics Prices Private Placement of Shares and Warrants for USD2.8 Million
Table 65: Xeris Pharma Raises USD42.7 Million in Public Offering of Shares
Table 66: Albireo Pharma Raises USD46 Million in Public Offering of Shares
Table 67: Guided Therapeutics Raises USD0.7 Million in Private Placement of Units
Table 68: PhysioLogic Devices Raises Funds through Financing
Table 69: Senseonics Plans to Raise up to USD50 Million in Public Offering of Shares
Table 70: Organogenesis Prices USD45 Million Public Offering of Shares
Table 71: Organogenesis Plans to Raise up to USD100 Million in Public Offering of Securities
Table 72: Xeris Pharma Plans to Raise up to USD50 Million in Public Offering of Shares
Table 73: Valeritas Holdings Plans to Raise up to USD10.7 Million in Public Offering of Shares
Table 74: Senseonics Holdings Raises USD25 Million in Public Offering of Shares
Table 75: Glucose Biosensor Systems Files Registration Statement for IPO of Shares
Table 76: MannKind to Raise up to USD50 Million in Public Offering of Shares
Table 77: Dance Biopharm Raises USD20.5 Million in Private Placement
Table 78: Abbott Labs and Insulet Enter into Partnership
Table 79: Biocorp Production Enters into Agreement with Amalgam Rx (iSage Rx)
Table 80: Senseonics Enters into Partnership with Companion Medical
Table 81: Abbott Labs Enters into Agreement with Bigfoot Biomedical
Table 82: Trividia Health and Mellitus Health Form Partnership
Table 83: Solys Diagnostics Enters into Licensing Agreement with Liquid Sensing
Table 84: Sanofi and Abbott Enter into Partnership
Table 85: Medtronic and Tidepool to Enter into Partnership
Table 86: LifeScan Enters into Distribution Agreement with Sanvita Medical
Table 87: Becton Dickinson Shareholders Reject Mini Tender Offer from TRC Capital
Table 88: Blackstone Group and Cinven May Bid for Smiths Medical
Table 89: AgaMatrix and WaveForm Technologies Raises USD56 Million in Financing
Table 90: Modular Medical to Raise Funds through Venture Financing
Table 91: Fractyl Labs Raises USD44.8 Million in Venture Financing
Table 92: Bigfoot Biomedical Raises USD45 Million in Initial Tranche of Series C Financing
Table 93: VivaChek Labs Raises USD14.2 Million in Series C Financing
Table 94: Hygieia Raises USD1.3 Million in Venture Financing
Table 95: Eccrine Systems Raises USD1.9 Million in Venture Financing
Table 96: Accessible Diagnostics Raises USD0.2 Million in Venture Financing
Table 97: Amalgam Rx (iSage Rx) Secures USD0.65 Million in Venture Financing
Table 98: MuscleSound Raises USD0.8 Million in Venture Financing
Table 99: Informed Data Systems (One Drop) Raises USD40 Million in Series B Financing
Table 100: TecMed Raises Funds through Venture Financing
Table 101: Thermalin Raises Additional USD12.2 Million in Venture Financing
Table 102: VivaChek Laboratories Raises Funds through Venture Financing
Table 103: POPS! Diabetes Care Secures USD6 Million in Series A Funding
Table 104: Beta Bionics Raises USD63 Million in Series B2 Financing
Table 105: Encellin Raises USD1.6 Million in Venture Financing
Table 106: Eccrine Systems Raises USD0.6 Million in Venture Financing
Table 107: PhysioLogic Devices to Raise USD3 Million in Venture Financing
Table 108: Intuity Medical (Rosedale Medical) Raises USD26.27 Million in Venture Financing
Table 109: Mighty Well Raises Funds through Venture Financing
List of Figures
Figure 1: Diabetes Care Devices Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 2: Diabetes Care Devices Market, United States, Revenue Mix ($m), 2019
Figure 3: Diabetes Care Devices Market, United States, Category Contribution (%), 2019
Figure 4: Diabetes Care Devices Market, United States, Revenue ($m), USD Constant, Historic, 2015-2025
Figure 5: Diabetes Care Devices Market, United States, Volume (Units), 2015-2025
Figure 6: Diabetes Care Devices Market, United States, Volume (Units), Historic, 2015-2025
Figure 7: Diabetes Care Devices Market, United States, Company Share (%) 2019
Figure 8: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 9: Blood Glucose Meters Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 10: Glucose Monitoring Market, United States, Volume (Units), 2015-2025
Figure 11: Blood Glucose Meters Market, United States, Volume (Units), 2015-2025
Figure 12: Glucose Monitoring Market, United States, Company Share (%) 2019
Figure 13: Insulin Delivery Market, United States, Revenue Mix ($m), 2019
Figure 14: Insulin Delivery Market, United States, Segment Contribution (%), 2019
Figure 15: Insulin Delivery Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 16: Insulin Pens Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 17: Insulin Pumps Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 18: Insulin Delivery Market, United States, Volume (Units), 2015-2025
Figure 19: Insulin Pens Market, United States, Volume (Units), 2015-2025
Figure 20: Insulin Pumps Market, United States, Volume (Units), 2015-2025
Figure 21: Insulin Delivery Market, United States, Company Share (%) 2019
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • DexCom Inc
  • Medtronic Plc
  • Novo Nordisk AS
Note: Product cover images may vary from those shown